Advances in Alzheimer’s diagnostics highlight systemic gaps in healthcare access and equity
Original framing: “STAT+: Improvements in Alzheimer’s testing could make diagnostics more accessible, informative” — STAT News
People of color, Indigenous communities, and low-income populations are disproportionately affected by Alzheimer’s but are often excluded from clinical trials and diagnostic development. Their voices are critical to shaping equitable healthcare solutions that address the root causes of health disparities.
Alzheimer’s diagnostics are advancing rapidly, but these innovations must be embedded within a broader systemic framework that addresses healthcare inequities, integrates diverse knowledge systems, and prioritizes the voices of marginalized communities.
Indigenous and cross-cultural models of care offer valuable insights into holistic, community-centered approaches that challenge the dominant biomedical paradigm. Future pathways must include inclusive clinical research, public investment in health infrastructure, and interdisciplinary collaboration to ensure that progress in diagnostics translates into meaningful, equitable outcomes for all.